Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets. The company completed its IPO [NASDAQ: RXRX] in 2021.

Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2016
  • IPO: 2021

• Founders

  • Chris Gibson, PhD
  • Blake Borgeson, PhD
  • Dean Li, PhD

  LUX Partners

  • Zavain Dar

• Latest Tweets

  • New beginnings 🧬 #RecursionIPO https://t.co/gxI9nuN2Dd@RecursionPharma - 04:14 PM Apr 16th
  • Thank you to all our #Recursionauts, investors and supporters along the way. #RecursionIPO (3/3)@RecursionPharma - 01:52 PM Apr 16th
  • Recursion will swing for the fences to make a meaningful impact; we will never become complacent about our pipeline… https://t.co/YGjoTBlpVY@RecursionPharma - 01:52 PM Apr 16th